GlaxoSmithKline Sells Australian Drugs to Aspen for $270 Million

15.08.2012 - GlaxoSmithKline advanced its clear-out of non-core drugs on Wednesday with a deal to sell 25 older brands marketed in Australia to South Africa's Aspen Pharmacare for 172 million...